The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is essential after percutaneous coronary intervention (PCI), while many studies have focused on determining the optimal degree of platelet inhibition and optimal DAPT duration to minimize complications after PCI. Current guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jeehoon, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031716/
https://www.ncbi.nlm.nih.gov/pubmed/29968428
http://dx.doi.org/10.4070/kcj.2018.0166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031716/
https://www.ncbi.nlm.nih.gov/pubmed/29968428
http://dx.doi.org/10.4070/kcj.2018.0166

Ejemplares similares